The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...

Alnylam Pharmaceuticals has agreed to drop its 2023 patent lawsuit against Moderna in a Delaware court following a judge's ...

This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking ...

What’s left of Johnson & Johnson’s infectious disease work continues to shrink, after the company announced Friday that it ...

Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...

Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million ...

The weather is getting cooler, but biotech’s recovery is heating up. After a years-long wait-and-see game exhausted many ...

DRI Healthcare Trust is paying $57 million upfront to the gene editing company in exchange for future licensing payments from Vertex, which struck an agreement with Editas to use its CRISPR/Cas9 gene ...

Flagship Pioneering's roots in Singapore are growing less than a year after the biotech incubator first unveiled its ...

Eli Lilly’s blockbuster GLP-1 drug tirzepatide is finally back on track in the US after two years of intermittent shortages ...

Frazier Life Sciences has added more than $630 million to its evergreen public fund, the firm said Wednesday. The long-only ...